Kyndryl director receives 17,844-share stock grant

JACKSON SHIRLEY A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

JACKSON SHIRLEY A reported acquisition or exercise transactions in this Form 4 filing.

Kyndryl Holdings, Inc. reports that director Shirley A. Jackson received an equity grant relating to 17,844 shares of common stock on July 30, 2026, recorded at $13.45 per share. A footnote explains this represents a grant of restricted stock units.

The RSUs will vest in full on the earlier of the first anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders, provided that the 2027 meeting occurs at least 50 weeks after the 2026 annual meeting. Following this grant, Jackson directly holds 84,656 shares of Kyndryl common stock.

Insider Trade Summary

Grant/Award: 17,844 shares

Grant/Award 1 txn

Insider JACKSON SHIRLEY A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	17,844	$13.45	$240K

Holdings After Transaction: Common Stock — 84,656 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).

Key Figures

Equity grant size: 17,844 shares Grant reference price: $13.45 per share Post-grant holdings: 84,656 shares +1 more

4 metrics

Equity grant size 17,844 shares Restricted stock unit grant to director on July 30, 2026

Grant reference price $13.45 per share Per-share value for the July 30, 2026 RSU-based grant

Post-grant holdings 84,656 shares Total direct Kyndryl common stock held by Shirley A. Jackson after the grant

Vesting condition Earlier of grant anniversary or 2027 annual meeting RSUs vest if 2027 meeting is at least 50 weeks after 2026 meeting

Key Terms

restricted stock units, Annual Meeting of Stockholders, Power of Attorney

3 terms

restricted stock units financial

"Represents a grant of restricted stock units which will vest in full"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Annual Meeting of Stockholders regulatory

"the date of the Issuer's 2027 Annual Meeting of Stockholders"

Power of Attorney regulatory

"Exhibit List - Exhibit 24.1 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Kyndryl (KD) report for Shirley A. Jackson?

Kyndryl reported that director Shirley A. Jackson received a grant tied to 17,844 shares of common stock as restricted stock units on July 30, 2026, at a reference value of $13.45 per share, as part of her equity compensation.

How many Kyndryl (KD) shares does Shirley A. Jackson hold after the latest grant?

After this award, Shirley A. Jackson directly holds 84,656 shares of Kyndryl common stock. This total reflects the addition of 17,844 RSU-based shares granted on July 30, 2026, as disclosed in the Form 4 insider transaction report.

When will the new restricted stock units granted at Kyndryl (KD) to Shirley A. Jackson vest?

The restricted stock units granted to Shirley A. Jackson vest in full on the earlier of the anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders, provided that the 2027 meeting is at least 50 weeks after the 2026 annual meeting.

What was the reference price for Shirley A. Jackson’s July 30, 2026 grant at Kyndryl (KD)?

The grant covering 17,844 shares for Shirley A. Jackson was recorded at $13.45 per share. This price is presented as a per-share value for the equity award and helps quantify the size of the director’s compensation-related grant.

Was Shirley A. Jackson’s July 30, 2026 Kyndryl (KD) grant made under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox was not affirmatively marked for this transaction. The filing treats the grant as a compensation-related award, not as an automatic purchase or sale under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 05:55 PM Accepted by SEC EDGAR 08/03/2026 - 05:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JACKSON SHIRLEY A

(Last) (First) (Middle)

ONE VANDERBILT AVENUE, 15TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Kyndryl Holdings, Inc. [ KD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/30/2026		A		17,844(1)	A	$13.45	84,656	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Ann Schlaffman, attorney-in-fact	08/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)